Given that obesity impacts approximately 40% of American adults, a quarter of them with severe obesity, 5 state coverage decisions for weight loss agents are a topic of significant clinical and budgetary consideration
Expert testimony on causation and labeling remains central to the litigation as the parties prepare for future dispositive motions and bellwether proceedings
PeptideStack does not manufacture, sell, distribute, prescribe, or compound peptides or medications
My appetite has been reduced dramatically, my gut does feel healthier (I guess the first week it was adjusting itself), and although I haven't been weighing myself I am starting to see the pounds come off
Whether someone is just starting GLP-1s or has been on them for a while, this guide explains what they might experience and how to help manage those symptoms
Semaglutide targets one receptor (GLP-1), while tirzepatide targets two (GIP + GLP-1)